PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
13-Feb-2024 New Veeva Vault Submissions Publishing eLearning Application Speeds Employee Onboarding Veeva Systems
12-Feb-2024 Novartis Cosentyx® (secukinumab) approved by SMC as the first biologic treatment in Scotland for chronic inflammatory skin condition since 2016 Novartis
12-Feb-2024 Novotech Publishes Candidiasis and Rheumatoid Arthritis Clinical Trial Landscape Reports to Support Biotech Research Planning Novotech
09-Feb-2024 Invitation to Semantic Data 2024: Taxonomy, Ontology and, Knowledge Graphs Henry Stewart Events
05-Feb-2024 Breaking Boundaries in Medical Device Sterilization: 5th Edition Excellence Conference marcus evans
31-Jan-2024 South East distributor moves into top gear following digital transformation About ACI Group
29-Jan-2024 Update on Regulatory Review of leriglitazone in the EU Minoryx Therapeutics
29-Jan-2024 LILLY RECEIVES MHRA MARKETING AUTHORISATION IN GREAT BRITAIN FOR TIRZEPATIDE (MOUNJARO ®▼) IN ALTERNATIVE KWIKPEN® PRESENTATION FOR TWO INDICATIONS Lilly
26-Jan-2024 Galen announces exclusive licensing agreement with Almeda Pharmaceuticals AG for new Microtabs Plus product. Galen
26-Jan-2024 Pistoia Alliance launches freely available IDMP Ontology 1.0, covering all five standards set by ISO The Pistoia Alliance
25-Jan-2024 The cause of long Covid has been identified – and it’s our own immune system London Medical Laboratory
16-Jan-2024 Launch of Scopus AI to Help Researchers Navigate the World of Research Elsevier,
10-Jan-2024 Burges Salmon advises Edinburgh-based biotech creation studio on £9m funding to support cancer research and accelerate treatment delivery Burges Salmon
10-Jan-2024 Pistoia Alliance Announces Dr Christian Baber as New Chief Portfolio Officer and Launches 2024 Project Pipeline The Pistoia Alliance
10-Jan-2024 Simris signs Head of Terms for an offtake agreement valued at minimum €2m / SEK 22m Simris Group AB (publ)
08-Jan-2024 Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals Bayer and RTW Investments, LP (“RTW”)
04-Jan-2024 Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2 Biocomposites
04-Jan-2024 InVivo Biosystems Secures New Investment to Accelerate CRISPR Innovation InVivo Biosystems
04-Jan-2024 The England areas with the longest distance to GP services Journo Research
04-Jan-2024 Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide Newron Pharmaceuticals